AstraZeneca Cancer Drug Hits Major Setback 08.19.02 Iressa's bad clinical results hit not only its maker, but also other firms developing targeted cancer drugs.
He says he believes researchers will soon publish results in a major medical journal that could lead to a diagnostic test that may predict whether drugs such as Tarceva and Iressa will work.